Delivery Order SPE2DX22D0010-SPE2D826FDC61

The Defense Logistics Agency Medical Supply Chain issued a $2,274 delivery order to Amerisourcebergen Drug Corp on February 11, 2026, for amphetamine mix (AD) extended-release capsules 25 mg, with ultimate completion by February 12, 2026. Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside. Amerisourcebergen Drug Corp is a division of Cencora, Inc., a major pharmaceutical distributor serving federal medical procurement needs through an indefinite delivery...

The Defense Logistics Agency Medical Supply Chain issued a $5,292.95 delivery order to Amerisourcebergen Drug Corp on February 11, 2026, for Amphetamine Mix (AD) Extended Release Capsules 30 mg, with an ultimate completion date of February 12, 2026. Place of performance is Conshohocken, PA. The order is priced on a firm fixed-price basis and carries no set-aside designation. Amerisourcebergen Drug Corp operates as a subsidiary of Cencora, Inc. and is a major pharmaceutical distributor serving...

<p>The Defense Logistics Agency Medical Supply Chain issued a $4,897.26 delivery order to Amerisourcebergen Drug Corp on February 18, 2026, for amphetamine mix (AD) extended-release capsules 30 mg, with an ultimate completion date of February 19, 2026.</p> <p>Place of performance is Conshohocken, PA. The order is priced firm fixed price with no set-aside applied.</p>

<p>The Defense Logistics Agency Medical Supply Chain issued a delivery order to Amerisourcebergen Drug Corp on February 9, 2026, with a ceiling value of $4,589.39 for amphetamine mix (AD) extended-release capsules, 20 mg.</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of February 10, 2026. No set-aside was used.</p>

The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $2,882.22 to AmerisourceBergen Drug Corp on January 20, 2026, for Amphetamine Mix (AD) Extended Release Capsules 10mg, with an ultimate completion date of January 21, 2026. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company...

<p>The Defense Logistics Agency Medical Supply Chain issued a $4,145.11 delivery order to Amerisourcebergen Drug Corp on February 18, 2026, for amphetamine mix extended-release capsules 20 mg.</p> <p>Place of performance is Conshohocken, PA. The order has a firm fixed price and an ultimate completion date of February 19, 2026. No set-aside was used.</p>

<p>The Defense Logistics Agency Medical Supply Chain issued a delivery order to Amerisourcebergen Drug Corp on February 6, 2026, for amphetamine mix (AD) extended-release capsules 30 mg with a ceiling value of $6,085.68.</p> <p>Place of performance is Conshohocken, PA. Ultimate completion date is February 9, 2026. The order is firm fixed price with no set-aside applied.</p>

<p>The Defense Logistics Agency Medical Supply Chain issued a delivery order to Amerisourcebergen Drug Corp on February 12, 2026, for amphetamine mix (AD) extended-release capsules 20 mg, with a ceiling value of $5,362.93.</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of February 13, 2026. No set-aside was used.</p>

<p>The Defense Logistics Agency's Medical Supply Chain issued a $5,524.32 delivery order to Amerisourcebergen Drug Corp on February 6, 2026, for amphetamine mix extended-release capsules 20 mg.</p> <p>Place of performance is Conshohocken, PA. The order carries a firm fixed price and is scheduled for completion by February 9, 2026. No set-aside was used.</p>

The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on February 4, 2026, for the supply of Amphetamine Mix (AD) Extended Release Capsules 20mg, valued at $2,654.34. This firm fixed-price delivery order, with an ultimate completion date of February 5, 2026, was awarded on a competitive basis without a set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, executed this order under its Corporate...